C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/90 (2006.01) A01K 67/027 (2006.01) A61K 35/32 (2006.01) A61K 49/00 (2006.01) C12N 5/10 (2006.01) C12N 15/00 (2006.01) C12Q 1/18 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2121582
2121582 9308301 PCTABS00021 The present invention relates to a method for determining the effect of a drug or a treatments, comprising introducing, in a non-human vertebrate recipient which may be an immunodeficient, e.g. a nude mouse, cells from a donor vertebrate, e.g. a human, which mediate the disease, the donor cell or cells of the recipient being modified, e.g. marked with a genetic marker such as lacZ gene, administering the drug or the treatment to the non-human recipient vertebrate, and determining the effect of the drug or the treatment. When the genetic marker is lacZ gene, the detection is performed by staining with the chromogenic substrate X-gal resulting in a blue staining of the labelled cell. In a further aspect, the invention relates to a method for controlling the progression of cancer cells in a human or animal patient, comprising administering to the patient fibroblasts which have been transformed with a genetic construct expressing a gene product inhibiting the progression of cancer cells.
Brunner Nils
Spang-Thomsen Mogens
Thompson Erik
Zwiebel James
Brunner Nils
Kræftens Bekæmpelse
Mccarthy Tetrault Llp
Spang-Thomsen Mogens
Thompson Erik
LandOfFree
An improved drugscreening method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with An improved drugscreening method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and An improved drugscreening method will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2072763